{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:50:10Z","timestamp":1791492610294,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477069"],"award-info":[{"award-number":["22477069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772827"],"award-info":[{"award-number":["2025M772827"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20250739"],"award-info":[{"award-number":["GZC20250739"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:32:35Z","timestamp":1784388755000},"page":"3732-3745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply"],"prefix":"10.1016","volume":"24","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changkai","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhe","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianli","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.07.009_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.07.009_bib2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/jth.13555","article-title":"A century of heparin: past, present and future","volume":"14","author":"Hemker","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African Swine Fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120303","article-title":"A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin","volume":"301","author":"Zhang","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jtha.2026.07.009_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619889406","article-title":"Comparative pharmacological profiles of various bovine, ovine, and porcine heparins","volume":"25","author":"Kouta","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211052293","article-title":"General considerations for diversifying heparin drug products by improving the current heparin manufacturing process and reintroducing bovine sourced heparin to the US market","volume":"27","author":"Al-Hakim","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231173965","article-title":"Blended heparin: a new perspective to guarantee the supply of a life-saving drug?","volume":"29","author":"Guerrini","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.2741\/2314","article-title":"Heparin-induced thrombocytopenia: impact of bovine versus porcine heparin in HIT pathogenesis","volume":"12","author":"Ahmad","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.jtha.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.jtha.2026.07.009_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100283","article-title":"Heparin-induced thrombocytopenia: an illustrated review","volume":"7","author":"May","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib11","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jca.20109","article-title":"Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly\/disassembly","volume":"22","author":"Cines","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jtha.2026.07.009_bib13","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2014-03-559518","article-title":"Binding of anti-platelet factor 4\/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4","volume":"124","author":"Kreimann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.14657","article-title":"Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins","volume":"18","author":"Nguyen","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.jtha.2026.07.009_bib16","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood-2005-05-1938","article-title":"Anti-platelet factor 4\/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin","volume":"106","author":"Warkentin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jps.23501","article-title":"Structural characterization of pharmaceutical heparins prepared from different animal tissues","volume":"102","author":"Fu","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jtha.2026.07.009_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-4975(02)04349-7","article-title":"Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery","volume":"75","author":"Francis","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.07.009_bib19","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2019-127304","article-title":"Bovine heparin demonstrates the same interaction with HIT antibodies as porcine heparin","volume":"134","author":"Walenga","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2018-99-118809","article-title":"Bovine heparin compared to porcine heparin to demonstrate bioequivalence","volume":"132","author":"Khiella","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib21","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2018-99-118781","article-title":"Comparing a new bovine source heparin to the clinically used porcine heparin for platelet function effects and heparin-induced thrombocytopenia potential","volume":"132","author":"Sung","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib22","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1182\/blood-2024-211016","article-title":"Unfractionated heparin resourced from bovine, ovine, and porcine origin is bioequivalent","volume":"144","author":"Thakkar","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib23","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood.V128.22.5027.5027","article-title":"Porcine and ovine mucosal heparins and their depolymerized derivatives are comparable in contrast to their bovine equivalents","volume":"128","author":"Bouchard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/1076029616685430","article-title":"Characterization of PF4-heparin complexes by photon correlation spectroscopy and zeta potential","volume":"23","author":"Bertini","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.xphs.2016.03.037","article-title":"Comparison of low-molecular-weight heparins prepared from bovine lung heparin and porcine intestine heparin","volume":"105","author":"Guan","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jtha.2026.07.009_bib26","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"Shi","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.009_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s42003-024-05982-4","article-title":"Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4","volume":"7","author":"Yang","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jtha.2026.07.009_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.009_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.07.009_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81396-w","article-title":"Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro","volume":"14","author":"Gratz","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2026.07.009_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carbpol.2018.05.070","article-title":"Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation","volume":"197","author":"Xie","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jtha.2026.07.009_bib32","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.07.009_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.954752","article-title":"Interactions of marine sulfated glycans with antithrombin and platelet factor 4","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:13:23Z","timestamp":1791490403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004393"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.009","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}